Freeze-Dried Presentation

  • AAHI’s freeze-dried, single-vial tuberculosis vaccine candidate, ID93+GLA-SE, is stable at sub-Saharan African ambient temperatures (37°C) for three months and refrigerated temperatures (4°C) for up to 24 months.
  • AAHI-SC2, AAHI’s saRNA-NLC COVID-19 vaccine candidate, freeze-dried is stable at refirgerated temperatures (4°C) for at least 18 months, at ambient temperatures (25°C) for three to six months, and at sub-Saharan African ambient temperatures (40°C) for up to one month.
x